Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis-Reference-Cited by-同舟云学术

Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis

Published:2020-01 Issue: Volume:139 Page:207-215
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Tan Aaron C.^ORCID,Lai Gillianne G.Y.,Tan Gek San,Poon Shou Yu,Doble Brett^ORCID,Lim Tse Hui,Aung Zaw Win,Takano Angela,Tan Wan Ling,Ang Mei-Kim,Tan Bien Soo,Devanand Anantham,Too Chow Wei,Gogna Apoorva,Ong Boon-Hean,Koh Tina P.T.,Kanesvaran Ravindran,Ng Quan Sing,Jain Amit,Rajasekaran Tanujaa,Lim Alvin S.T.,Lim Wan Teck,Toh Chee Keong,Tan Eng-Huat,Lim Tony Kiat Hon,Tan Daniel S.W.^ORCID

Funder

Singapore Ministry of Health's National Medical Research Council

Open-Fund Large Collaborative

Clinician-Scientist Award

National Cancer Centre Research Fund

Lung Cancer Consortium Singapore

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference44 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J. Clin.,2015